ROSY F20 (Fenofibrate (145mg) + Rosuvastatin (20mg))

Rosycap-F 20 Tablet consists of a combination of two medications designed to reduce lipid levels in the bloodstream, specifically targeting cholesterol and triglycerides. This treatment is indicated for individuals who have not achieved adequate lipid control through lifestyle modifications alone, such as a low-fat diet. By effectively lowering these lipid levels, the medication plays a crucial role in minimizing the risk of cardiovascular diseases. Patients are advised to take the tablet either with food or on an empty stomach, and it is beneficial to maintain a consistent daily schedule for dosing to enhance adherence. The appropriate dosage will be determined by a healthcare provider based on individual lipid levels and treatment response. It is important to note that many individuals with elevated cholesterol and triglycerides may not experience symptoms; hence, discontinuing the medication could result in worsening lipid levels, increasing the likelihood of heart disease and stroke. Regular monitoring of cholesterol and triglyceride levels is essential as part of a broader health strategy that includes a balanced diet, physical activity, cessation of smoking, moderation of alcohol consumption, and weight management. While on this medication, patients should maintain regular eating habits but limit high-fat foods. Commonly reported side effects include nausea, abdominal discomfort, constipation, headaches, excessive gas, and muscle aches. These effects are typically mild and transient. However, if symptoms persist or if there are signs of jaundice, unusual bleeding, or persistent muscle pain, a healthcare professional should be consulted. Routine monitoring of liver function may be advised during therapy. The use of this medication is contraindicated in patients with liver disease and should be approached with caution in individuals with kidney issues. It is crucial to inform the doctor about any existing conditions, especially regarding kidney or liver health, as well as pregnancy or lactation status. Additionally, patients with diabetes should monitor their blood glucose levels during treatment as this medication may influence those levels.